GQ-201 Proof-of-Concept Results presented at Gene Therapy Conference [ 11 Jun 2014 ]

Data of the proof-of-concept study with GeneQuine’s lead candidate GQ-201 were featured in two presentations in May 2014 at the leading gene therapy congress ‘American Society of Gene and Cell Therapy Annual Meeting’.

In one of the talks, Dr. Alan Nixon of Cornell University presented the outstanding results of the study and emphasized the potential of the therapy for the treatment of osteoarthritis in horses. Alan Nixon – one of the leading equine surgeons and researchers in equine orthopedics – is the principal investigator of GeneQuine’s proof-of-concept study.